Brief: Erytech Pharma SA Secures U.S. Patent Directed To Sequential Use Of Methioninase & Asparaginase Against Solid Tumors

Phaxiam Therapeutics SA

29/11/2021 21:08

Nov 29 (Reuters) - Erytech Pharma SA  ERYP.PA :
    * ERYTECH PHARMA SA - SECURES US PATENT DIRECTED TO
SEQUENTIAL USE
OF METHIONINASE & ASPARAGINASE AGAINST SOLID TUMORS

Source text for Eikon:  ID:nGNX13jM3F 
Further company coverage:  ERYP.PA